Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
BIOREM Inc. is a clean technology company specializing in air emissions control systems based on biofiltration. The company designs, engineers, and supplies biological air treatment solutions that remove odors, volatile organic compounds (VOCs), and hazardous air pollutants from industrial and municipal sources. BIOREM operates within the environmental engineering, air pollution control, and cleantech infrastructure industries, serving customers that must comply with increasingly stringent environmental regulations.
The company’s primary revenue is generated from the sale, installation, and servicing of proprietary biofilter, biotrickling filter, and hybrid air treatment systems. Its core customers include municipal wastewater treatment facilities, industrial manufacturers, and solid waste management operators. BIOREM’s strategic positioning is based on its long operating history in biofiltration, patented system designs, and a reputation for delivering large-scale, permanent emissions control infrastructure. The company was founded in 1990 and has evolved from a regional engineering firm into an international supplier of biological air treatment systems. Public disclosure confirms continuous operations since inception; however, publicly available sources provide inconsistent attribution regarding the original founder, and data is inconclusive based on available public sources.
Business Operations
BIOREM conducts its business through integrated engineering, manufacturing, project delivery, and aftermarket service activities. The company generates revenue through system design and fabrication, project-based construction contracts, and ongoing maintenance and media replacement services. Operations are commonly described under a single operating segment focused on air emissions control systems, as reported in public filings, rather than multiple distinct business segments.
The company controls proprietary system designs, engineered bio-media, and process configurations that differentiate its solutions from conventional chemical or thermal treatment alternatives. BIOREM conducts both domestic and international operations, supported by manufacturing, engineering, and project management teams. It operates through wholly owned subsidiaries, including BIOREM Technologies Inc. in the United States. Public disclosures also reference European operations conducted through BIOREM Europe AG; however, the current scale and operational scope of this entity are not consistently detailed across public sources, and some subsidiary activity data is inconclusive.
Strategic Position & Investments
BIOREM’s strategic direction emphasizes growth through global demand for sustainable air treatment infrastructure, driven by tighter environmental regulations and increased public scrutiny of industrial emissions. The company focuses on expanding its installed base of systems, which supports recurring aftermarket revenue from service contracts and consumables. Growth initiatives have historically centered on penetrating new municipal and industrial markets rather than diversification into unrelated technologies.
Public records do not indicate a strategy heavily reliant on large-scale acquisitions; instead, BIOREM has prioritized organic growth and incremental investment in proprietary system enhancements. The company continues to refine biological treatment efficiency, system footprint optimization, and long-term operating cost reductions. While management communications reference ongoing product development, disclosures do not consistently specify material investments in emerging technologies beyond core biofiltration, and detailed information on R&D allocation remains limited in public filings.
Geographic Footprint
BIOREM is headquartered in Canada, with its corporate office and primary engineering functions located in Ontario. The company has a significant operational presence in the United States, which represents one of its largest end markets, particularly in the municipal wastewater and waste management sectors.
Internationally, BIOREM has delivered projects across Europe, Asia, the Middle East, and Latin America, reflecting a broad geographic reach for a company of its size. Its systems are installed in multiple continents, often supporting large municipal infrastructure projects. While project delivery is global, permanent operational facilities outside North America are limited, and the extent of ongoing regional operations varies by market conditions and project backlog.
Leadership & Governance
BIOREM is led by an executive team with long-standing experience in environmental engineering and emissions control. The leadership emphasizes regulatory compliance, engineering reliability, and long-term customer relationships as core elements of its governance philosophy. Strategic communications consistently highlight disciplined capital management and a focus on sustainable, infrastructure-driven growth.
Key executives include:
- Derek S. Webb – President & Chief Executive Officer
- Michael B. Andrews – Chief Financial Officer
- Bradley A. Ratz – Vice President, Engineering
- Robert McIlhargey – Vice President, Sales & Marketing
Public disclosures confirm the roles listed above; however, historical executive tenure and founder attribution vary across sources. Where discrepancies exist, leadership role information reflects the most consistently reported positions in recent regulatory filings and company disclosures.